FDA OKs First Interchangeable Biosimilars for Denosumab

(MedPage Today) -- The FDA approved injectable Jubbonti and Wyost as the first interchangeable biosimilars to denosumab (Prolia, Xgeva), and for all the same indications, including the prevention of fractures in at-risk adults and skeletal-related...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news